Combined analysis of six Lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: Cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 4, 2006, Pages 1438-1445

  Wittrup, Hans H ^a   Andersen, Rolf V ^a   Tybjærg Hansen, Anne ^b,c   Jensen, Gorm B ^c   Nordestgaard, Børge G ^a,c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ASPARAGINE; ASPARTIC ACID; CYSTEINE; GLUTAMIC ACID; GLYCINE; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; SERINE; THREONINE; TRIACYLGLYCEROL; APOLIPOPROTEIN A1; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; BLOOD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DENMARK; FOLLOW UP; GENE FREQUENCY; GENETICS; HEART MUSCLE ISCHEMIA; MIDDLE AGED; NUCLEOTIDE SEQUENCE; RISK; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN A-I; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; RISK; TRIGLYCERIDES; VARIATION (GENETICS);

EID: 33646054594     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1725     Document Type: Article

References (22)

1. Brunzell JD, Deeb SS 2001 Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic, molecular bases of inherited disease, 8th Ed. New York: McGraw-Hill; 2789-2816
2. Merkel M, Eckel RH, Goldberg IJ 2002 Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 43:1997-2006
3. Fischer RM, Humphries SE, Talmud PJ 1997 Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 135:145-159
4. Hokanson JE 1999 Functional variants in the lipoprotein lipase gene and risk of cardiovascular disease. Curr Opin Lipidol 10:393-399
5. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG 1999 Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 99:2901-2907
6. Kastelein JJP, Ordovas JM, Wittekoek ME, Pimstone SN, Wilson PWF, Gagné SE, Larson MG, Schaefer EJ, Boer JM, Gerdes C, Hayden MR 1999 Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women. Clin Genet 56:297-305
7. Hall S, Chu G, Miller G, Cruickshank K, Cooper JA, Humphries SE, Talmud PJ 1997 A common mutation in the lipoprotein lipase promoter, -93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro. Arterioscler Thromb Vasc Biol 17:1969-1976
8. Yang W-S, Nevin DN, Iwasaki L, Peng R, Greg Brown B, Brunzell JD, Deeb SS 1996 Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease. J Lipid Res 37:2627-2637
9. Zhang H, Henderson H, Gagne SE, Clee SM, Miao L, Liu G, Hayden MR 1996 Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta 1302:159-166
10. Peterson J, Ayyobi AF, Ma Y, Henderson H, Reina M, Deeb SS, Santamarina-Fojo S, Hayden MR, Brunzell JD 2002 Structural and functional consequences of missense mutations in exon 5 of the lipoprotein lipase gene. J Lipid Res 43:398-406
11. Fischer RM, Benhizia F, Schreiber R, Makoveichuk E, Putt W, Al-Haideri M, Deckelbaum RJ, Olivecrona G, Humphries SE, Talmud PJ 2003 Enhanced bridging function and augmented monocyte adhesion by lipoprotein lipase N9: insights into increased risk of coronary artery disease in N9 carriers. Atheroslerosis 166:243-251
12. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M 2001 The Copenhagen City Heart Study. Østerbroundersøgelsen. Tables with data from the third examination 1991-1994. Eur Heart J 3(Suppl H):1-83
13. Wittrup HH, Tybjaerg-Hansen A, Abildgaard S, Steffensen R, Schnohr P, Nordestgaard BG 1997 A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J Clin Invest 99:1606-1613
14. Nordestgaard BG, Abildgaard S, Wittrup HH, Steffensen R, Jensen G, Tybjærg-Hansen A 1997 Heterozygous lipoprotein lipase deficiency. Frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation 96:1737-1744
15. Wittrup HH, Tybjaerg-Hansen A, Steffensen R, Deeb SS, Brunzell JD, Jensen G, Nordestgaard BG 1999 Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen City Heart Study. Arterioscler Thromb Vasc Biol 19:1535-1540
16. Wittrup HH, Nordestgaard BG, Sillesen H, Schnohr P, Tybjaerg-Hansen A 2000 A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men. Circulation 101:2393-2397
17. Wittrup HH, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A 2002 Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study. Atherosclerosis 165:119-126
18. Task Force of the European Society of Cardiology 1997 Management of stable angina pectoris: recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 18:394-413
19. Tybjaerg-Hansen A, Steffensen R, Meinertz H, Schnohr P, Nordestgaard BG 1998 Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. N Engl J Med 338:1577-1584
20. Frikke-Schmidt R, Tybjaerg-Hansen A, Steffensen R, Jensen G, Nordestgaard BG 2000 Apolipoprotein E genotype: ε32 women are protected while ε43 and ε44 men are susceptible to ischemic heart disease. The Copenhagen City Heart Study. J Am Coll Cardiol 35:1192-1199
21. Frikke-Schmidt R, Nordestgaard BG, Agerholm-Larsen B, Schnohr P, Tybjærg-Hansen A 2000 Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J Lipid Res 41:1812-1822
22. Song Y, Stampfer MJ, Liu S 2004 Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141:137-147